Results 121 to 130 of about 14,197 (209)
PD-L1<sup>+</sup> plasma cells suppress T lymphocyte responses in patients with sepsis and mouse sepsis models. [PDF]
Nat CommunGossez M, Vigneron C, Vandermoeten A, Lepage M, Courcol L, Coudereau R, Paidassai H, Jallades L, Lopez J, Kandara K, Ortillon M, Mommert M, Fabri A, Peronnet E, Grosjean C, Buisson M, Lukaszewicz AC, Rimmelé T, Argaud L, Cour M, REALISM study group, RICO study group, Py BF, Thaunat O, Defrance T, Monneret G, Venet F. +26 moreeuropepmc +1 more sourceCorrection: Structural basis for plant plasma membrane protein dynamics and organization into functional nanodomains.
Elife, 2021 Gronnier J, Crowet JM, Habenstein B, Nasir MN, Bayle V, Hosy E, Platre MP, Gouguet PB, Raffaele S, Martinez D, Grelard A, Loquet A, Simon-Plas F, Gerbeau-Pissot P, Der C, Bayer EM, Jaillais Y, Deleu M, Germain V, Lins L, Mongrand S. +20 moreeuropepmc +1 more sourceImpact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19. [PDF]
Ann Intensive CareLe Terrier C, Walter T, Lebbah S, Hajage D, Sigaud F, Guérin C, Desmedt L, Primmaz S, Joussellin V, Della Badia C, Ricard JD, Pugin J, Terzi N, COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. +13 moreeuropepmc +1 more sourceCOVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases. [PDF]
RMD Open, 2022 Bourguiba R, Kyheng M, Koné-Paut I, Rouzaud D, Avouac J, Devaux M, Abdallah NA, Fautrel B, Ferreira-Maldent N, Langlois V, Ledoult E, Nielly H, Queyrel V, Sellam J, Tieulie N, Chazerain P, Evon P, Labreuche J, Savey L, Hentgen V, Grateau G, Georgin-Lavialle S, FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. +22 moreeuropepmc +1 more sourceVentilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection: risk factors and prognosis. [PDF]
Crit CareRazazi K, Luyt CE, Voiriot G, Rouzé A, Garnier M, Ferré A, Camous L, Heming N, Lapidus N, Charles-Nelson A, Mekontso-Dessap A, COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. +11 moreeuropepmc +1 more sourceExtracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis. [PDF]
Am J Respir Crit Care Med, 2022 Hajage D, Combes A, Guervilly C, Lebreton G, Mercat A, Pavot A, Nseir S, Mekontso-Dessap A, Mongardon N, Mira JP, Ricard JD, Beurton A, Tachon G, Kontar L, Le Terrier C, Richard JC, Mégarbane B, Keogh RH, Belot A, Maringe C, Leyrat C, Schmidt M, COVID-ICU Investigators. +22 moreeuropepmc +1 more source